,66 Such dual functionality may be advantageous in autoimmune disease, where selective suppression or depletion of PD-1+ effector cells could enhance therapeutic efficacy while maintaining overall immune homeostasis. This evidence concerns the gene PDCD1 and autoimmune disease.